Works matching IS 10834389 AND DT 2018 AND VI 23


Results: 95
    1
    2
    3
    4
    5
    6
    7
    8

    Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double‐blind, placebo‐controlled trial.

    Published in:
    Helicobacter, 2018, v. 23, n. 5, p. 1, doi. 10.1111/hel.12529
    By:
    • McNicholl, Adrian G.;
    • Molina‐Infante, Javier;
    • Lucendo, Alfredo J.;
    • Calleja, José Luis;
    • Pérez‐Aisa, Ángeles;
    • Modolell, Inés;
    • Aldeguer, Xavier;
    • Calafat, Margalida;
    • Comino, Luis;
    • Ramas, Mercedes;
    • Callejo, Ángel;
    • Badiola, Carlos;
    • Serra, Jordi;
    • Gisbert, Javier P.
    Publication type:
    Article
    9
    10
    11

    Helicobacter pylori and non‐alcoholic fatty liver disease: A new enigma?

    Published in:
    Helicobacter, 2018, v. 23, n. 6, p. N.PAG, doi. 10.1111/hel.12537
    By:
    • Abdel‐Razik, Ahmed;
    • Mousa, Nasser;
    • Shabana, Walaa;
    • Refaey, Mohamed;
    • Elhelaly, Rania;
    • Elzehery, Rasha;
    • Abdelsalam, Mostafa;
    • Elgamal, Ayman;
    • Nassar, Mervat R.;
    • Abu El‐Soud, Atef;
    • Seif, Ahmed S.;
    • Tawfik, Ahmed M.;
    • El‐Wakeel, Niveen;
    • Eldars, Waleed
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Issue Information.

    Published in:
    Helicobacter, 2018, v. 23, n. 6, p. N.PAG, doi. 10.1111/hel.12436
    Publication type:
    Article
    18
    19

    keyword Intex.

    Published in:
    Helicobacter, 2018, v. 23, p. 1, doi. 10.1111/hel.12527
    Publication type:
    Article
    20

    Issue Information.

    Published in:
    Helicobacter, 2018, v. 23, n. 5, p. 1, doi. 10.1111/hel.12435
    Publication type:
    Article
    21

    Author Index.

    Published in:
    Helicobacter, 2018, v. 23, p. 1, doi. 10.1111/hel.12526
    Publication type:
    Article
    22

    Abstracts.

    Published in:
    2018
    Publication type:
    Abstract
    23
    24

    Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.

    Published in:
    Helicobacter, 2018, v. 23, n. 5, p. 1, doi. 10.1111/hel.12496
    By:
    • Xie, Yong;
    • Zhang, Zhenyu;
    • Hong, Junbo;
    • Liu, Wenzhong;
    • Lu, Hong;
    • Du, Yiqi;
    • Wang, Weihong;
    • Xu, Jianming;
    • Wang, Xuehong;
    • Huo, Lijuan;
    • Zhang, Guiying;
    • Lan, Chunhui;
    • Li, Xiaoyan;
    • Li, Yanqing;
    • Wang, Hong;
    • Zhang, Guoxin;
    • Zhu, Yin;
    • Shu, Xu;
    • Chen, Ye;
    • Wang, Jiangbin
    Publication type:
    Article
    25
    26
    27

    Gastric cancer: Basic aspects.

    Published in:
    Helicobacter, 2018, v. 23, p. 1, doi. 10.1111/hel.12523
    By:
    • Duarte, Henrique O.;
    • Gomes, Joana;
    • Machado, José C.;
    • Reis, Celso A.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    The “three‐in‐one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12502
    By:
    • Zagari, Rocco Maurizio;
    • Romiti, Alessandra;
    • Ierardi, Enzo;
    • Gravina, Antonietta G.;
    • Panarese, Alba;
    • Grande, Giuseppe;
    • Savarino, Edoardo;
    • Maconi, Giovanni;
    • Stasi, Elisa;
    • Eusebi, Leonardo Henry;
    • Farinati, Fabio;
    • Conigliaro, Rita;
    • Bazzoli, Franco;
    • Romano, Marco
    Publication type:
    Article
    39

    Issue Information.

    Published in:
    Helicobacter, 2018, v. 23, p. 1, doi. 10.1111/hel.12513
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12498
    By:
    • Hsu, Ping‐I;
    • Pan, Chao‐Yu;
    • Kao, John Y.;
    • Tsay, Feng‐Woei;
    • Peng, Nan‐Jing;
    • Kao, Sung‐Shuo;
    • Wang, Huay‐Min;
    • Tsai, Tzung‐Jiun;
    • Wu, Deng‐Chyang;
    • Chen, Chien‐Lin;
    • Tsai, Kuo‐Wang;
    • the Taiwan Acid‐related Disease (TARD) Study Group
    Publication type:
    Article
    48
    49
    50

    Issue Information.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12434
    Publication type:
    Article